Zimmer Partners’s Akoya BioSciences AKYA Stock Holding History

Zimmer Partners’s Portfolio AKYA Stock Details AKYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,000	Closed	-$387K	–	144
2021 Q2	$387K	Buy	+20,000	New	+$413K	0.01%	163

Other funds holding AKYA

BOTOTLSJU

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Zimmer Partners's AKYA Position: Q3 2021 in Review

Zimmer Partners sold out of Akoya BioSciences (AKYA) in Q3 2021, closing a stake of 20,000 shares — an estimated $387K sold.

Zimmer Partners first reported a position in AKYA in Q2 2021 and held it in 1 quarter. The position peaked at $387K in Q2 2021. 47 funds tracked by Wall St. Rank hold AKYA as of Q3 2021.

Zimmer Partners reported no remaining Akoya BioSciences position as of Q3 2021 after selling out during the quarter.
Zimmer Partners sold 20,000 Akoya BioSciences shares in Q3 2021, an estimated $387K.
Zimmer Partners first reported a position in Akoya BioSciences in Q2 2021 and held it in 1 quarter.
Zimmer Partners's Akoya BioSciences position peaked at $387K in Q2 2021.
47 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2021.

Based on Zimmer Partners's 13F filing for Q3 2021, filed 15 Nov 2021.